Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sergei N. Shchelkunov is active.

Publication


Featured researches published by Sergei N. Shchelkunov.


Journal of Clinical Microbiology | 2004

Real-Time PCR System for Detection of Orthopoxviruses and Simultaneous Identification of Smallpox Virus

Victoria A. Olson; Thomas Laue; Miriam T. Laker; Igor V. Babkin; Christian Drosten; Sergei N. Shchelkunov; Matthias Niedrig; Inger K. Damon; Hermann Meyer

ABSTRACT A screening assay for real-time LightCycler (Roche Applied Science, Mannheim, Germany) PCR identification of smallpox virus DNA was developed and compiled in a kit system under good manufacturing practice conditions with standardized reagents. In search of a sequence region unique to smallpox virus, the nucleotide sequence of the 14-kDa fusion protein gene of each of 14 variola virus isolates of the Russian World Health Organization smallpox virus repository was determined and compared to published sequences. PCR primers were designed to detect all Eurasian-African species of the genus Orthopoxvirus. A single nucleotide mismatch resulting in a unique amino acid substitution in smallpox virus was used to design a hybridization probe pair with a specific sensor probe that allows reliable differentiation of smallpox virus from other orthopoxviruses by melting-curve analysis. The applicability was demonstrated by successful amplification of 120 strains belonging to the orthopoxvirus species variola, vaccinia, camelpox, mousepox, cowpox, and monkeypox virus. The melting temperatures (Tms) determined for 46 strains of variola virus (Tms, 55.9 to 57.8°C) differed significantly (P = 0.005) from those obtained for 11 strains of vaccinia virus (Tms, 61.7 to 62.7°C), 15 strains of monkeypox virus (Tms, 61.9 to 62.2°C), 40 strains of cowpox virus (Tms, 61.3 to 63.7°C), 8 strains of mousepox virus (Tm, 61.9°C), and 8 strains of camelpox virus (Tms, 64.0 to 65.0°C). As most of the smallpox virus samples were derived from infected cell cultures and tissues, smallpox virus DNA could be detected in a background of human DNA. By applying probit regression analysis, the analytical sensitivity was determined to be 4 copies of smallpox virus target DNA per sample. The DNAs of several human herpesviruses as well as poxviruses other than orthopoxviruses were not detected by this method. The assay proved to be a reliable technique for the detection of orthopoxviruses, with the advantage that it can simultaneously identify variola virus.


Journal of Virology | 2000

Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense.

Scott A. Smith; Nicholas P. Mullin; John Parkinson; Sergei N. Shchelkunov; Alexei V. Totmenin; Vladimir N. Loparev; Ratchapin Srisatjaluk; David N. Reynolds; Kristen L. Keeling; David E. Justus; Paul N. Barlow; Girish J. Kotwal

ABSTRACT Vaccinia virus complement control protein (VCP) has been shown to possess the ability to inhibit both classical and alternative complement pathway activation. The newly found ability of this protein to bind to heparin has been shown in previous studies to result in uptake by mast cells, possibly promoting tissue persistence. It has also been shown to reduce chemotactic migration of leukocytes by blocking chemokine binding. In addition, this study shows that VCP—through its ability to bind to glycosaminoglycans (heparin-like molecules) on the surface of human endothelial cells—is able to block antibody binding to surface major histocompatibility complex class I molecules. Since heparin binding is critical for many functions of this protein, we have attempted to characterize the molecular basis for this interaction. Segments of this protein, generated by genetic engineering of the DNA encoding VCP into the Pichia pastoris expression system, were used to localize the regions with heparin binding activity. These regions were then analyzed to more specifically define their properties for binding. It was found that the number of putative binding sites (K/R-X-K/R), the overall positive charge, and the percentage of positively charged amino acids within the protein were responsible for this interaction.


FEBS Letters | 1993

Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms

Sergei N. Shchelkunov; Vladimir Blinov; Lev S. Sandakhchiev

Analysis of variola virus nucleotide sequence revealed proteins belonging to several families which provide the virus with the possibility of overcoming the barriers of specific and non‐specific host defence against viral infection. The complement‐binding proteins, lymphokine‐binding proteins, and serine protease inhibitors can be assigned to this type, as can the proteins providing the orthopoxviruses with resistance to interferon. The revealed differences between the genes (proteins) of variola and vaccinia viruses under study are discussed.


FEBS Letters | 2001

Human monkeypox and smallpox viruses: genomic comparison

Sergei N. Shchelkunov; Alexei V. Totmenin; Igor V. Babkin; Pavel F. Safronov; Olga I. Ryazankina; Nikolai A. Petrov; Valery V. Gutorov; E. A. Uvarova; Maxim Vyacheslavovich Mikheev; Jerry R. Sisler; Joseph J. Esposito; Peter B. Jahrling; Bernard Moss; Lev S. Sandakhchiev

Monkeypox virus (MPV) causes a human disease which resembles smallpox but with a lower person‐to‐person transmission rate. To determine the genetic relationship between the orthopoxviruses causing these two diseases, we sequenced the 197‐kb genome of MPV isolated from a patient during a large human monkeypox outbreak in Zaire in 1996. The nucleotide sequence within the central region of the MPV genome, which encodes essential enzymes and structural proteins, was 96.3% identical with that of variola (smallpox) virus (VAR). In contrast, there were considerable differences between MPV and VAR in the regions encoding virulence and host‐range factors near the ends of the genome. Our data indicate that MPV is not the direct ancestor of VAR and is unlikely to naturally acquire all properties of VAR.


Virus Research | 1995

Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses

Sergei N. Shchelkunov; Robert F. Massung; Joseph J. Esposito

The nucleotide sequences of genome DNAs and the deduced amino acid sequences of proteins from potential open reading frames (ORFs) of variola smallpox viruses from outbreaks in India in 1967 and in Bangladesh in 1975 have been compared and the analyses of the sequences are updated. Alignment of the DNAs revealed 99.3% base sequence identity. Of the 200 potential encoded proteins of each virus, 122 were identical, 42 showed substitution of a single amino acid, 11 showed two residues changes, and the remainder were more diverged. The variant proteins were encoded mainly in the near-terminal regions of each genome. The most conserved region between the variola DNAs included ORFs A33L to A49R, which is a relatively poorly conserved region compared with vaccinia virus.


Journal of Virological Methods | 2003

Detection and discrimination of orthopoxviruses using microarrays of immobilized oligonucleotides

Majid Laassri; Vladimir Chizhikov; Maxim Vyacheslavovich Mikheev; Sergei N. Shchelkunov; Konstantin Chumakov

Variola virus (VARV), causing smallpox, is a potential biological weapon. Methods to detect VARV rapidly and to differentiate it from other viruses causing similar clinical syndromes are needed urgently. We have developed a new microarray-based method that detects simultaneously and discriminates four orthopoxvirus (OPV) species pathogenic for humans (variola, monkeypox, cowpox, and vaccinia viruses) and distinguishes them from chickenpox virus (varicella-zoster virus or VZV). The OPV gene C23L/B29R, encoding the CC-chemokine binding protein, was sequenced for 41 strains of seven species of orthopox viruses obtained from different geographical regions. Those C23L/B29R sequences and the ORF 62 sequences from 13 strains of VZV (selected from GenBank) were used to design oligonucleotide probes that were immobilized on an aldehyde-coated glass surface (a total of 57 probes). The microchip contained several unique 13-21 bases long oligonucleotide probes specific to each virus species to ensure redundancy and robustness of the assay. A region approximately 1100 bases long was amplified from samples of viral DNA and fluorescently labeled with Cy5-modified dNTPs, and single-stranded DNA was prepared by strand separation. Hybridization was carried out under plastic coverslips, resulting in a fluorescent pattern that was quantified using a confocal laser scanner. 49 known and blinded samples of OPV DNA, representing different OPV species, and two VZV strains were tested. The oligonucleotide microarray hybridization technique identified reliably and correctly all samples. This new procedure takes only 3 h, and it can be used for parallel testing of multiple samples.


Virus Research | 1994

ANALYSIS OF THE NUCLEOTIDE SEQUENCE OF 23.8 KBP FROM THE LEFT TERMINUS OF THE GENOME OF VARIOLA MAJOR VIRUS STRAIN INDIA-1967

Sergei N. Shchelkunov; Alex V. Totmenin; Lev S. Sandakhchiev

Sequencing and computer analysis of a variola major virus strain India-1967 (VAR-IND) genome segment (53,018 bp) from the right terminal region has been carried out. Fifty-nine potential open reading frames (ORFs) of over 60 amino acid residues were identified. Structure-function organization of the VAR-IND DNA segment was compared with the previously reported sequences from the analogous genomic regions of vaccinia virus strains Copenhagen (VAC-COP) and Western Reserve (VAC-WR) and variola virus strain Harvey (VAR-HAR). Multiple differences between VAR-IND and the strains of VAC but the high identity of VAR-IND with VAR-HAR in the genetic maps are revealed. Possible functions of the predicted viral proteins and the effect of their differences on the features of orthopoxviruses are discussed.


FEBS Letters | 1993

Comparison of the genetic maps of variola and vaccinia viruses

Sergei N. Shchelkunov; Sergei M. Resenchuk; Alexei V. Totmenin; Vladimir Blinov; Svetlana S. Marennikova; Lev S. Sandakhchiev

The complete genetic map of the variola major virus strain India‐1967 is built basing on the sequence data. The suggested map is compared with the maps of the sequenced genomic regions of Copenhagen and Western Reserve strains of vaccinia virus and Harvey strain of variola major virus. The principle differences revealed in the genomic organization of these viruses are discussed.


Journal of Leukocyte Biology | 1998

Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat.

Jeremy Howard; David E. Justus; Alexei V. Totmenin; Sergei N. Shchelkunov; Girish J. Kotwal

Microorganisms encode numerous immunomodulators that resemble, in structure and function, molecules captured over the millennia from their hosts [G. J. Kotwal J. Leukoc. Biol. 62, 415–429]. The vaccinia virus complement control protein (VCP) was the first soluble microbial protein to have a postulated role in the immunomodulation and evasion of host defense [G. J. Kotwal and B. Moss Nature 355, 176–179]. Purified bioactive VCP has been shown to bind to C3 and C4, block the complement cascade at multiple sites [G. J. Kotwal et al. Science 250, 827–830; R. Mckenzie, G. J. Kotwal et al. J. Infect. Dis. 166, 1245–1250] and exhibit a greater potency than the human complement 4b binding protein, C4b‐BP [G. J. Kotwal, Am. Biotech. Lab. 9,76]. The importance of this protein to poxviruses was further demonstrated in rabbits and guinea pigs through the use of recombinant virus lacking an intact DNA coding for VCP [Isaacs, G. J. Kotwal, and B. Moss Proc. Natl. Acad. Sci. 89, 628–672]. Studies in mice have shown that the homolog of VCP in cowpox virus (CPV), referred to as the inflammation modulatory protein (IMP) can, in a mouse model, significantly diminish the specific footpad swelling response [C. G. Miller, S. N. Shchelkunov, and G. J. Kotwal Virol. 229, 126–133]. To determine the precise cellular changes at the site of infection, BALB/c mice were subcutaneously injected (in the backs) with CPV or a recombinant virus lacking IMP, CPV‐IMP. Differences in histology were observed by staining the adjoining skin tissue sections with hematoxylin & eosin or by removal of the connective tissue and staining with May‐Grunwald‐Geimsa. All mice that were injected with the CPV‐IMP experienced severe tissue destruction and formation of nodular lesions compared with the mice injected with CPV. Microscopic examination indicated significantly greater cellular infiltration and destruction of skeletal muscle cells in the sections of connective tissue and adjoining skin tissue, respectively, of the mice injected with the CPV‐IMP [G. J. Kotwal et al. Mol. Cell. Biochem. in press]. Thus IMP preserves the tissue at the site of infection (viral habitat). In this review, we present evidence for molecular mimicry and evolutionary relationship to other homologs of IMP and discuss their relationships with other IMPs such as the poxviral chemokine and cytokine receptor‐like proteins. J. Leukoc. Biol. 64: 68–71; 1998.


FEBS Letters | 1993

Ankyrin-like proteins of variola and vaccinia viruses

Sergei N. Shchelkunov; Vladimir Blinov; Lev S. Sandakhchiev

Computer analysis of full coding sequences of variola major virus strain India‐1967 genome and vaccinia virus strain Copenhagen genome have been carried out. A wide set of proteins containing ankyrin‐like repeats have been identified for both viruses. Only three proteins of this family of the studied viruses are highly homologous. The rest of the proteins are different. The possible role of such proteins in determination of virus tissue tropism is discussed.

Collaboration


Dive into the Sergei N. Shchelkunov's collaboration.

Top Co-Authors

Avatar

Alexei V. Totmenin

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Top Co-Authors

Avatar

Lev S. Sandakhchiev

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Top Co-Authors

Avatar

I. P. Gileva

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Top Co-Authors

Avatar

Pavel F. Safronov

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Top Co-Authors

Avatar

Joseph J. Esposito

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

E. A. Uvarova

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Top Co-Authors

Avatar

Elena V. Gavrilova

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Top Co-Authors

Avatar

Leonid R. Lebedev

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Top Co-Authors

Avatar

Valery V. Gutorov

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Top Co-Authors

Avatar

Rinat A. Maksyutov

State Research Center of Virology and Biotechnology VECTOR

View shared research outputs
Researchain Logo
Decentralizing Knowledge